Skip to content

Category: U.S. Food and Drug AdministrationSyndicate content

SNM applauds House action to build medical isotopes reactor in the US

November 6, 2009

Reston, Va. -- SNM applauds the U.S. House of Representatives for its passage of H.R. 3276 -- the American Medical Isotopes Production Act of 2009.

Laser etching safe alternative for labeling grapefruit

November 3, 2009

LAKE ALFRED, FL -- Laser labeling of fruit and vegetables is a new, patented technology in which a low-energy carbon dioxide laser beam is used to label, or "etch" information on produce, thereby e

Pandemic flu vaccine campaigns may be undermined by coincidental medical events

October 30, 2009

CINCINNATI -- The effectiveness of pandemic flu vaccination campaigns -- like that now underway for H1N1 -- could be undermined by the public incorrectly associating coincidental and unrelated h

INTUNIV demonstrated symptom reduction on oppositional subscale Conners' ADHD rating scale

October 30, 2009

HONOLULU - October 29, 2009 -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV? (guanfacine) Extended Release Tablets, a

TGen seeks emergency FDA approval of new swine flu test

October 29, 2009

FLAGSTAFF, Ariz. -- Oct.

IOM recommends new nutritional requirements for school meal programs

October 20, 2009

WASHINGTON -- The National School Lunch Program and the School Breakfast Program should adopt a new set of nutrient targets and standards for menu planning, says a new report from the Institute of Medicine. The recommended targets and standards would update and improve the programs' abilities to meet children's nutritional needs and foster healthy eating habits.

Patent challenges reduce pharmaceutical innovation and productivity, researchers suggest

October 15, 2009

The development of new and innovative pharmaceuticals is being stifled by a U.S. law and successful patent challenges that embolden generic competition, according to an article published in this week's issue of the journal Science.

New guidelines identify best treatments to help ALS patients live longer, easier

October 12, 2009

ST. PAUL, Minn. -- New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.

Investigation of contaminated heparin syringes highlights medication safety issues

October 12, 2009

An outbreak of bloodstream infections appears to have been caused by the contamination of pre-filled heparin and saline syringes made by a single company, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Vaccinating boys against human papillomavirus not cost-effective

October 8, 2009

Boston, MA -- Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Current guidelines prioritize HPV vaccination of pre-adolescent girls, which has been shown to be cost-effective in previous studies, but the value of vaccinating boys in the United States has been unclear.

Cocaine vaccine may help some reduce drug use

October 5, 2009

A vaccine to treat cocaine dependence appears to reduce use of the drug in a subgroup of individuals who attain high anticocaine antibody levels in response, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Designing drugs and their antidotes together improves patient care

October 4, 2009

DURHAM, N.C. -- Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately -- because the blood thinner and antidote were designed to work together.

Mount Sinai leads large multicenter study finding evidence that a drug might slow Parkinson's

September 23, 2009

Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report today in The New England Journal of Medicine that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.